Cover Image

Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy

Objective: To investigate the potential mechanisms underlying the protective effects of recombinant human erythropoietin (rhEPO) and carbamylated EPO (CEPO) against myocardial cell apoptosis in epilepsy. Methods: Rats were given an intra-amygdala injection of kainic acid to induce epilepsy. Groups o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bao-Xin Ma, MD (Author), Jie Li, MD (Author), Hua Li, MD (Author), Sui-Sheng Wu, MD (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo
by: Samaka RM, et al.
Published: (2019)

Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes
by: Ankit Srivastava, et al.
Published: (2018)

Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris
by: Farag AGA, et al.
Published: (2019)

Biotechnologically Produced Lavandula angustifolia Mill. Extract Rich in Rosmarinic Acid Resolves Psoriasis-Related Inflammation Through Janus Kinase/Signal Transducer and Activator of Transcription Signaling
by: Ivanka K. Koycheva, et al.
Published: (2021)

Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways
by: Xiaowen Wang, et al.
Published: (2022)

Anisodamine Maintains the Stability of Intervertebral Disc Tissue by Inhibiting the Senescence of Nucleus Pulposus Cells and Degradation of Extracellular Matrix via Interleukin-6/Janus Kinases/Signal Transducer and Activator of Transcription 3 Pathway
by: Ning Tang, et al.
Published: (2020)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020)

Disparities in Janus kinase inhibitor access for alopecia areata: a retrospective analysis
by: Elizabeth J. Klein, MD, et al.
Published: (2024)

Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
by: David Nash, BHSc, et al.
Published: (2023)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

The signal transducer and activator of transcription factors lodge in immunopathogenesis of rheumatoid arthritis
by: F. Zare, et al.
Published: (2016)

Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
by: Nicolas Caudrelier, MD, et al.
Published: (2023)

The critical role of signal transducers and activators of transcription-3 in the proliferation of vascular smooth muscle cells
by: Shuai Li, et al.
Published: (2023)

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
by: Sang-Doo Lee, MD, et al.
Published: (2022)

Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib
by: Jannett Nguyen, MD, et al.
Published: (2021)

A case of Merkel cell carcinoma development under treatment with a Janus kinase inhibitor
by: Yuta Koike, MD, PhD, et al.
Published: (2017)

Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future
by: Roberto Bursi, et al.
Published: (2021)

Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010)

Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010)

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
by: Abrahim Abduelmula, BScN, et al.
Published: (2022)

Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator
by: Hyeok-Jin Kwon, MD, et al.
Published: (2021)

Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis
by: Ji Eun Jeong, et al.
Published: (2017)

Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review
by: Siddhartha Sood, HBSc, et al.
Published: (2024)

Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
by: Charles Dunn, MD, et al.
Published: (2023)

Signal Transducer and Activator of Transcription 3 in Keratinocytes Regulates Histaminergic Itch but Not Nonhistaminergic Itch
by: Takashi Hashimoto, et al.
Published: (2019)

Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
by: Fabienne Ballanger, et al.
Published: (2023)

Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway
by: Yoseph Toni Wijaya, et al.
Published: (2022)

Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma
by: Indre Valiulyte, et al.
Published: (2017)

A critique on nuclear factor-kappa B and signal transducer and activator of transcription 3: The key transcription factors in periodontal pathogenesis
by: Ranjith Ambili, et al.
Published: (2017)

A case of aggressive squamous cell carcinoma with lymphovascular invasion during treatment with the Janus kinase inhibitor tofacitinib
by: Ahmad I. Aleisa, MD, et al.
Published: (2020)

Basics of Janus kinases: a review
by: Hanan R Nada, et al.
Published: (2020)

Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012)

Interleukin-27 decreases ghrelin production through signal transducer and activator of transcription 3-mechanistic target of rapamycin signaling
by: Heng Zhang, et al.
Published: (2020)

Interleukin-27 Ameliorates Renal Ischemia-Reperfusion Injury through Signal Transducers and Activators of Transcription 3 Signaling Pathway
by: Peihui Zhou, et al.
Published: (2019)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020)

Effects of Magnoliae Flos on Atopic Dermatitis-Like Inflammation Evaluated via Extracellular Signal-regulated Kinase or Signal Transducers and Activators of Transcription 1/3 Signalling Pathways
by: Tae-Young Gil, et al.
Published: (2023)

Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response
by: Ding X, et al.
Published: (2019)